- Home
- TZUP vs ICCC Comparison
TZUP vs ICCC Comparison
Compare TZUP & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZUP
- ICCC
- Stock Information
- Founded
- TZUP 2020
- ICCC 1982
- Country
- TZUP United States
- ICCC United States
- Employees
- TZUP N/A
- ICCC N/A
- Industry
- TZUP
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- TZUP
- ICCC Health Care
- Exchange
- TZUP NYSE
- ICCC Nasdaq
- Market Cap
- TZUP 38.8M
- ICCC 39.2M
- IPO Year
- TZUP N/A
- ICCC 1987
- Fundamental
- Price
- TZUP $4.22
- ICCC $5.37
- Analyst Decision
- TZUP
- ICCC
- Analyst Count
- TZUP 0
- ICCC 0
- Target Price
- TZUP N/A
- ICCC N/A
- AVG Volume (30 Days)
- TZUP 144.6K
- ICCC 16.7K
- Earning Date
- TZUP 01-01-0001
- ICCC 05-13-2025
- Dividend Yield
- TZUP N/A
- ICCC N/A
- EPS Growth
- TZUP N/A
- ICCC N/A
- EPS
- TZUP N/A
- ICCC N/A
- Revenue
- TZUP $741.00
- ICCC $26,493,169.00
- Revenue This Year
- TZUP N/A
- ICCC N/A
- Revenue Next Year
- TZUP N/A
- ICCC N/A
- P/E Ratio
- TZUP N/A
- ICCC N/A
- Revenue Growth
- TZUP N/A
- ICCC 51.63
- 52 Week Low
- TZUP $2.02
- ICCC $3.34
- 52 Week High
- TZUP $7.89
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- TZUP N/A
- ICCC 63.55
- Support Level
- TZUP N/A
- ICCC $4.56
- Resistance Level
- TZUP N/A
- ICCC $5.05
- Average True Range (ATR)
- TZUP 0.00
- ICCC 0.28
- MACD
- TZUP 0.00
- ICCC 0.08
- Stochastic Oscillator
- TZUP 0.00
- ICCC 82.33
About TZUP THUMZUP MEDIA CORP
Thumzup Media Corp operates in the social media branding and marketing industry. The company operates in a single business segment which is social media marketing. The Thumzup App works on both iPhone and Android mobile operating systems and connects brands and people who use and love these brands. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through Venmo and PayPal.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.